Gary D. Hammer
Founder en Sling Therapeutics, Inc. .
Perfil
Gary D.
Hammer was the founder of Millendo Therapeutics US, Inc. established in 2012, where he held the title of Chairman-Scientific Advisory Board.
He is also the founder of Sling Therapeutics, Inc. Dr. Hammer's current job is Director-Endocrine Oncology Program & Professor at the University of Michigan, where he has been working since 1999.
Dr. Hammer's former job was as Principal at The Endocrine Society.
Dr. Hammer earned his doctorate degree from Tufts University School of Medicine.
Cargos activos de Gary D. Hammer
| Empresas | Cargo | Inicio |
|---|---|---|
| University of Michigan | Corporate Officer/Principal | 01/01/1999 |
Sling Therapeutics, Inc.
 Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | Founder | - |
Antiguos cargos conocidos de Gary D. Hammer.
| Empresas | Cargo | Fin |
|---|---|---|
| The Endocrine Society | Corporate Officer/Principal | - |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Founder | - |
Formación de Gary D. Hammer.
| Tufts University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
| The Endocrine Society | |
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | Commercial Services |
- Bolsa de valores
- Insiders
- Gary D. Hammer
